Evidence map›Paper›PMID 25058163›Full record

ArticlePLoS pathogens2014

The CD27L and CTP1L endolysins targeting Clostridia contain a built-in trigger and release factor.

Matthew Dunne, Haydyn D T Mertens, Vasiliki Garefalaki, Cy M Jeffries, Andrew Thompson, Edward A Lemke, Dmitri I Svergun, Melinda J Mayer, Arjan Narbad, Rob Meijers

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Matthew DunneEuropean Molecular Biology Laboratory (EMBL), Hamburg, Germany.
Haydyn D T MertensEuropean Molecular Biology Laboratory (EMBL), Hamburg, Germany.
Vasiliki GarefalakiEuropean Molecular Biology Laboratory (EMBL), Hamburg, Germany.
Cy M JeffriesEuropean Molecular Biology Laboratory (EMBL), Hamburg, Germany.
Andrew ThompsonSynchrotron Soleil, L'Orme des Merisiers, Saint Aubin, Gif sur Yvette, France.
Edward A LemkeEuropean Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
Dmitri I SvergunEuropean Molecular Biology Laboratory (EMBL), Hamburg, Germany.
Melinda J MayerInstitute of Food Research, Colney, Norwich, United Kingdom.
Arjan NarbadInstitute of Food Research, Colney, Norwich, United Kingdom.
Rob MeijersEuropean Molecular Biology Laboratory (EMBL), Hamburg, Germany.
European Molecular Biology Laboratory · DENorwich Research Park · GBQuadram Institute · GBSynchrotron soleil · FR

Funding

Biotechnology and Biological Sciences Research Council BB/J004529/1Biotechnology and Biological Sciences Research Council BBS/E/F/00044453Biotechnology and Biological Sciences Research Council IFR/08/1
6 · The paper itself

Abstract

The bacteriophage ΦCD27 is capable of lysing Clostridium difficile, a pathogenic bacterium that is a major cause for nosocomial infection. A recombinant CD27L endolysin lyses C. difficile in vitro, and represents a promising alternative as a bactericide. To better understand the lysis mechanism, we have determined the crystal structure of an autoproteolytic fragment of the CD27L endolysin. The structure covers the C-terminal domain of the endolysin, and represents a novel fold that is identified in a number of lysins that target Clostridia bacteria. The structure indicates endolysin cleavage occurs at the stem of the linker connecting the catalytic domain with the C-terminal domain. We also solved the crystal structure of the C-terminal domain of a slow cleaving mutant of the CTP1L endolysin that targets C. tyrobutyricum. Two distinct dimerization modes are observed in the crystal structures for both endolysins, despite a sequence identity of only 22% between the domains. The dimers are validated to be present for the full length protein in solution by right angle light scattering, small angle X-ray scattering and cross-linking experiments using the cross-linking amino acid p-benzoyl-L-phenylalanine (pBpa). Mutagenesis on residues contributing to the dimer interfaces indicates that there is a link between the dimerization modes and the autocleavage mechanism. We show that for the CTP1L endolysin, there is a reduction in lysis efficiency that is proportional to the cleavage efficiency. We propose a model for endolysin triggering, where the extended dimer presents the inactive state, and a switch to the side-by-side dimer triggers the cleavage of the C-terminal domain. This leads to the release of the catalytic portion of the endolysin, enabling the efficient digestion of the bacterial cell wall.

Indexed as

BacteriophagesClostridioides difficileEndopeptidasesModels, BiologicalViral ProteinsCrystallography, X-RayHumansProtein Structure, TertiaryendolysinEndopeptidasesViral Proteins

Identifiers

PMID25058163
PMCPMC4110038
OpenAlexW2021341846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.